Xingmu
Hefei
About Xingmu
Xingmu creates cutting-edge gene editing technologies and gene therapy solutions for ocular illnesses.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: starrygene.com
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Medical
Canonical: https://fsome.com/organization/xingmu-2662454 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.